The proliferation and angiogenesis of malignant astrocytomas in humans depends on signaling through the RAS network, and common changes observed in gliomas include EGFR amplification and activating mutations, early activation of receptor tyrosine kinase signaling, NF-1 deletion, and increased levels of p21 signaling [58]. Here, EGFR is linked to central nervous system cancer.